4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-001668
Chief Executive Officer sold 5,532 shares at $4.06 ($22,483)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2022-01-04 | Sale | −5,532 | $4.06 | $22,483 | 6,172 | D |
| Open-market sales · 5,532 sh · avg $4.06 · $22,483 | |||||||
Loading xslF345X03/tm221700-1_4seq1.xml…